Platelet alpha-granule proteins

Platelet alpha-granules are the most numerous secretory organelles within platelets, serving as a storage reservoir for a diverse range of proteins critical to vascular biology (Blair & Flaumenhaft, 2009). Upon platelet activation, these granules undergo exocytosis, releasing over 300 different proteins including adhesion molecules like P-selectin and von Willebrand factor, coagulation factors such as Factor V and fibrinogen, and various growth factors and chemokines (Golebiewska & Poole, 2015). This release is fundamental to the formation of a stable blood clot, the recruitment of leukocytes to sites of injury, and the initiation of tissue repair processes (StatPearls, 2023). While the collective group of alpha-granule proteins is not a single therapeutic target, individual components are highly relevant in clinical medicine. For example, P-selectin is targeted by drugs like crizanlizumab to reduce vaso-occlusive crises in sickle cell disease, and von Willebrand factor is a target for treating thrombotic microangiopathies (Ataga et al., 2017). Deficiencies in these proteins or their secretion mechanisms, such as in Gray Platelet Syndrome, result in bleeding disorders and highlight their essential role in maintaining hemostasis (Gunay-Aygun et al., 2010).

Other names

Alpha-granule cargoPlatelet secretory proteinsAlpha-granule proteomePlatelet alpha-granule components

Therapeutic agents target specific proteins stored within alpha-granules to modulate platelet adhesion, leukocyte recruitment, or ligand availability, while other agents stimulate the release of these stored factors to compensate for deficiencies.